Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tetanus vaccine relationship to Guillain-Barre not determinable -- HHS proposed vaccine table rule.

Executive Summary

TETANUS VACCINE DATA "INSUFFICIENT" TO SHOW RELATIONSHIP TO GBS, HHS finds in a proposed rule published in the Nov. 8 Federal Register. HHS departs from recommendations made by both the Institute of Medicine and the Advisory Commission on Childhood Vaccines in its conclusion that "the scientific evidence is insufficient to accept or reject a causal relationship between vaccines containing tetanus toxoid and Guillain-Barre Syndrome." GBS is an acute inflammatory demyelinating polyneuropathy marked by an initially progressive motor paralysis.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS027284

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel